Cite
HARVARD Citation
Rothenberg, M. et al. (n.d.). S387 Dupilumab Improves Clinical, Symptomatic, Histologic, and Endoscopic Aspects of EoE up to 24 Weeks: Pooled Results From Parts A and B of Phase 3 LIBERTY-EoE-TREET. American journal of gastroenterology. pp. e269-e270. [Online].